Does Gilead Sciences have any ongoing clinical trials?

Yes, Gilead Sciences is actively involved in numerous ongoing clinical trials. As a leader in the biopharmaceutical industry, we are committed to advancing scientific research and developing innovative therapies. These trials are conducted to evaluate the safety and efficacy of potential treatments across a wide range of therapeutic areas, including HIV/AIDS, viral hepatitis, oncology, respiratory diseases, and inflammation. Our clinical trials follow strict regulatory guidelines and involve collaborations with healthcare professionals and research institutions worldwide. By continually investing in clinical research, Gilead Sciences aims to bring forth new treatment options that can improve patients' lives and address unmet medical needs. To learn more about our ongoing trials, please visit our website or contact our Clinical Trials team directly.